Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. (Q48674565)
Jump to navigation
Jump to search
scientific article published in March 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. |
scientific article published in March 2002 |
Statements
1 reference
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. (English)
1 reference
Henry S Friedman
1 reference
Darell D Bigner
1 reference
Allan H Friedman
1 reference
David A Reardon
1 reference
Roger E McLendon
1 reference
Jeremy N Rich
1 reference
R Edward Coleman
1 reference
Jennifer A Quinn
1 reference
James E Herndon
1 reference
James M Provenzale
1 reference
Michael R Zalutsky
1 reference
Gamal Akabani
1 reference
Charles N Pegram
1 reference
Xiao-Guang Zhao
1 reference
Ilkcan Cokgor
1 reference
Carol J Wikstrand
1 reference
Lorna V Regalado
1 reference
John H Sampson
1 reference
Timothy D Shafman
1 reference
Terence Z Wong
1 reference
1 March 2002
1 reference
1 reference
20
1 reference
1389-1397
1 reference
5
1 reference
Identifiers
1 reference
1 reference